Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer. - Gao Y; Li LX; Rowland A; Karapetis CS; Parent N; Kichenadasse G; Hopkins AM; Sorich MJ (Cancer letters, 2026)